Danielle Roy/X
Dec 18, 2025, 09:49
Clotting and Bleeding Risks in Cancer: Links to Inflammatory and Cardiac Biomarkers by Danielle Roy et al.
Danielle Roy, Clinical Research Assistant at Health Sciences North Research Institute, shared on X:
“Cancer patients face competing risks of clotting and bleeding. Our new European Heart Journal study shows associations with inflammatory and cardiac biomarkers.”
Title: Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers
Authors: Danielle Carole Roy, Tzu-Fei Wang, Ranjeeta Mallick, Dylan Burger, Marc Carrier, Philip Wells, Steven Hawken.
Find more posts on Hemostasis Today.
-
Jul 2, 2026, 17:17Nico Gagelmann: Launching Myths and Facts on Hematology and Cell Therapy
-
Jul 2, 2026, 17:05Haroun Gajraj: Understanding the Technology Behind Spider Vein Treatment
-
Jul 2, 2026, 16:44Ney Carter Borges: Is It Time to Personalize Antiplatelet Therapy?
-
Jul 2, 2026, 16:22Introducing a New Resource for the ITP Community – ITP Support Association
-
Jul 2, 2026, 16:22Shinto Francis Thekkudan: Delegates Visiting our BMT and Hematology Department from Kazhakstan
-
Jul 2, 2026, 16:13William Aird: When Deciding whether an Adult Patient is Anemic, Which Do You Usually Use?
-
Jul 2, 2026, 16:08Supporting Bleeding Disorders Community and Celebrating ASPEH Milestone – WFH
-
Jul 2, 2026, 15:59Raul Santos: Why Does LDL-C Remain Elevated in Many Patients?
-
Jul 2, 2026, 15:16Tim Patel: How Regular Movement Helps Keep Blood Flowing Throughout the Day